ENRIQUE GUTIERREZ: Open Payments
NPI 1407951304 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$870 in 41 payments from 19 companies in 2025. Trend: 2023 $1,196 · 2024 $624 · 2025 $870
Food & beverage: $870
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $99 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $98 |
| Novo Nordisk Inc | 4 | $78 |
| PFIZER INC. | 3 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $68 |
| ViiV Healthcare Company | 4 | $67 |
| Merck Sharp & Dohme LLC | 2 | $52 |
| EMD Serono, Inc. | 3 | $50 |
| Corcept Therapeutics | 2 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
Products named: JARDIANCE, Kerendia, DOVATO, PIFELTRO, Korlym, ELIQUIS, Wegovy, Ozempic.
Industry payments across FL — which companies pay providers there.
